June 22, NYC: BrainHealth- VC Panel + GTM

​BrainHealth innovation can be difficult to scale. It scales when Founders, clinicians, investors, operators, regulators and budget owners challenge each other to think bigger, reduce friction and demonstrate substantial ROI. On Monday, June 22nd, 5:30pm, join an information-packed session in Midtown NYC focused on practical go-to-market strategies and real world lessons from CEOs and institutional BrainHealth VCs. If you are building, investing in, or supporting BrainHealth innovation - this is the room for you. Confirmed speakers (more to come):

​Moderator: Richard Hatzfeld, Co-Lead, Global Health Impact, FINN Partners https://www.linkedin.com/in/richard-hatzfeld-9a61634

​VC Panel:

​a) Jeremy Sohn, Managing Partner, P74 Bio and P74 Ventures https://www.linkedin.com/in/jeremysohn

​b) Gal Noyman Veksler PhD, Partner, LionBird https://www.linkedin.com/in/gal-noyman-veksler-phd-4622b939

​c) Dr. Maria Blekher, Managing Partner, Serendipity Impact VC https://www.linkedin.com/in/drmariablekher

​Go-To-Market Keynote: Esther Howard, CEO, Bezyl https://www.linkedin.com/in/esther-howard-7352b3b3/

​Don't miss this chance to meet thought leaders / investors from Phoenix, Boston, Tel Aviv and Washington DC. Food and beverage provided. Secure your spot for "BrainHealth- VC + GTM", Monday, June 22nd, 5:30pm at FINN Partners, 55th & Broadway.